$359m pro-forma cash! That's after tax amount.
2025 annual royalties will be around $65m.
Europe sales may come as early as Q2, 2025, expected to be approved in Q1, 2026.
Canada sales in Q3,2025.
Annual royalties for next year, is likely to reach $100m, imo.
Cash burn rate might not as high as I expected,
2024 R&D: $33m
Corporate & administrative: $4.7m
Total: $37.7m for the year.
- Forums
- ASX - By Stock
- Ann: 2024 results - A$166m comprehensive income for shareholders
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$12.54

$359m pro-forma cash! That's after tax amount. 2025 annual...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.000(0.00%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.32 | $7.219M | 577.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2968 | $12.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.57 | 540 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2968 | 12.510 |
1 | 1399 | 12.490 |
1 | 1592 | 12.480 |
1 | 1342 | 12.470 |
4 | 3622 | 12.450 |
Price($) | Vol. | No. |
---|---|---|
12.570 | 540 | 1 |
12.580 | 1000 | 1 |
12.620 | 1592 | 1 |
12.630 | 2217 | 6 |
12.640 | 1592 | 1 |
Last trade - 16.16pm 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |